Business Description
Nanologica AB
ISIN : SE0005454873
Compare
Compare
Traded in other countries / regions
NICA.Sweden4YD.Germany IPO Date
2021-05-04Description
Nanologica AB develops and manufactures nanoporous silica particles for life science applications. It focuses on two areas: Drug Development and Chromatography. The company's drug delivery platforms are NLAB Spiro and NLAB Silica, which focus on producing medicines for the benefit of patients. Its geographical segments are Sweden, China, India, the United States, and the Rest of the world.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.03 | |||||
| Equity-to-Asset | -0.09 | |||||
| Debt-to-Equity | -0.45 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -7.81 | |||||
| Beneish M-Score | -1.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -61.1 | |||||
| 3-Year EBITDA Growth Rate | -40.6 | |||||
| 3-Year EPS without NRI Growth Rate | -20.1 | |||||
| 3-Year FCF Growth Rate | 9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.99 | |||||
| 9-Day RSI | 36.9 | |||||
| 14-Day RSI | 37.16 | |||||
| 6-1 Month Momentum % | -63.9 | |||||
| 12-1 Month Momentum % | -81.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | |||||
| Quick Ratio | 0.41 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 569.63 | |||||
| Days Sales Outstanding | 84.59 | |||||
| Days Payable | 769.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.2 | |||||
| Shareholder Yield % | -29.72 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.82 | |||||
| Operating Margin % | -747.74 | |||||
| Net Margin % | -1119.86 | |||||
| FCF Margin % | -966.67 | |||||
| ROE % | -894.66 | |||||
| ROA % | -88.83 | |||||
| ROIC % | -74.17 | |||||
| ROC (Joel Greenblatt) % | -430.55 | |||||
| ROCE % | -133.93 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 5.3 | |||||
| PS Ratio | 8.67 | |||||
| EV-to-EBIT | -1.7 | |||||
| EV-to-Forward-EBIT | -8.48 | |||||
| EV-to-EBITDA | -2.13 | |||||
| EV-to-Forward-EBITDA | -12.41 | |||||
| EV-to-Revenue | 17.9 | |||||
| EV-to-Forward-Revenue | 13.9 | |||||
| EV-to-FCF | -1.87 | |||||
| Earnings Yield (Greenblatt) % | -58.55 | |||||
| FCF Yield % | -53.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanologica AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.699 | ||
| EPS (TTM) (€) | -0.191 | ||
| Beta | 0.09 | ||
| Volatility % | 63.83 | ||
| 14-Day RSI | 37.16 | ||
| 14-Day ATR (€) | 0.007371 | ||
| 20-Day SMA (€) | 0.1365 | ||
| 12-1 Month Momentum % | -81.04 | ||
| 52-Week Range (€) | 0.118 - 0.923596 | ||
| Shares Outstanding (Mil) | 82.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nanologica AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanologica AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nanologica AB Frequently Asked Questions
What is Nanologica AB(FRA:4YD)'s stock price today?
The current price of FRA:4YD is €0.12. The 52 week high of FRA:4YD is €0.92 and 52 week low is €0.12.
When is next earnings date of Nanologica AB(FRA:4YD)?
The next earnings date of Nanologica AB(FRA:4YD) is 2025-02-07.
Does Nanologica AB(FRA:4YD) pay dividends? If so, how much?
Nanologica AB(FRA:4YD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers